L Isaac1, M P Florido, D Fecchio, L M Singer. 1. Departamento de Imunologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, Brazil. louisaac@icb.usp.br
Abstract
OBJECTIVE AND DESIGN: To determine the alpha-2-macroglobulin (alpha2M) levels in mice during acute and chronic inflammatory responses. MATERIALS AND METHODS: Inflammation was induced by one of the following stimuli: carrageenin, zymosan, lipopolysacharide, thioglycollate, bacilli Calmette Guerin, PPD (in pre-immunized and non-immunized animals) and tumor cells. The concentration of alpha2M was determined in plasma or peritoneal liquid by electroimmunoassay. RESULTS: In all the treatments employed, the plasma levels of alpha2M were higher than in untreated animals. This increase varied from 9%, 24 h after injection up a maximum of 66% 72 h post-injection. When compared to animals injected only with saline, the increases were significant 48 h after treatment with either zymosan or LPS, and 72 h after treatment with either thioglycollate or carrageenin. Treatment with BCG triggers an increase in alpha2M levels after 24 h (18.60%) and 48 h (27.90%). Immunized mice presented higher levels of this protein than non-immunized animals after challenge with PPD. The growth of Ehrlich tumor cells in the peritoneal cavity was directly correlated with the local levels of alpha2M which increased 3.5 fold, 10 days after injection. CONCLUSIONS: These results strongly indicate that in mice, the concentration of alpha2M can increase during acute and chronic inflammatory reactions with kinetics dependent on the particular kind of inflammatory agent.
OBJECTIVE AND DESIGN: To determine the alpha-2-macroglobulin (alpha2M) levels in mice during acute and chronic inflammatory responses. MATERIALS AND METHODS: Inflammation was induced by one of the following stimuli: carrageenin, zymosan, lipopolysacharide, thioglycollate, bacilli Calmette Guerin, PPD (in pre-immunized and non-immunized animals) and tumor cells. The concentration of alpha2M was determined in plasma or peritoneal liquid by electroimmunoassay. RESULTS: In all the treatments employed, the plasma levels of alpha2M were higher than in untreated animals. This increase varied from 9%, 24 h after injection up a maximum of 66% 72 h post-injection. When compared to animals injected only with saline, the increases were significant 48 h after treatment with either zymosan or LPS, and 72 h after treatment with either thioglycollate or carrageenin. Treatment with BCG triggers an increase in alpha2M levels after 24 h (18.60%) and 48 h (27.90%). Immunized mice presented higher levels of this protein than non-immunized animals after challenge with PPD. The growth of Ehrlich tumor cells in the peritoneal cavity was directly correlated with the local levels of alpha2M which increased 3.5 fold, 10 days after injection. CONCLUSIONS: These results strongly indicate that in mice, the concentration of alpha2M can increase during acute and chronic inflammatory reactions with kinetics dependent on the particular kind of inflammatory agent.
Authors: Jung Hun Oh; Jeffrey M Craft; Reid Townsend; Joseph O Deasy; Jeffrey D Bradley; Issam El Naqa Journal: J Proteome Res Date: 2011-02-16 Impact factor: 4.466
Authors: Thais A Amamura; Tatiana R Fraga; Sílvio A Vasconcellos; Angela S Barbosa; Lourdes Isaac Journal: Front Microbiol Date: 2017-05-30 Impact factor: 5.640
Authors: Ekaterina A Skomorokhova; Tatiana P Sankova; Iurii A Orlov; Andrew N Savelev; Daria N Magazenkova; Mikhail G Pliss; Alexey N Skvortsov; Ilya M Sosnin; Demid A Kirilenko; Ivan V Grishchuk; Elena I Sakhenberg; Elena V Polishchuk; Pavel N Brunkov; Alexey E Romanov; Ludmila V Puchkova; Ekaterina Yu Ilyechova Journal: Nanotechnol Sci Appl Date: 2020-12-31